15 results
8-K
EX-10.1
ARVN
Arvinas Inc
22 Jul 21
Arvinas and Pfizer Announce Global Collaboration to Develop and Commercialize PROTAC® Protein
7:30am
or filing or record retention requirements) by a Party leads to the imposition of withholding tax liability or VAT on the other Party that would
8-K
EX-1.1
3clwzrkxb5 bi6
18 Dec 20
Arvinas, Inc. Announces Pricing of $400 Million Public Offering of Common Stock
6:30am
8-K
EX-1.1
gku4sl krml
12 Nov 19
Arvinas, Inc. Announces Pricing of Public Offering of Common Stock
4:02pm
DEF 14A
tzfg3pj
12 Apr 19
Definitive proxy
5:02pm
DRS/A
EX-4.3
cv7dww d0492q2y4
2 Aug 18
Draft registration statement (amended)
12:00am
DRS/A
zvzc30g8
2 Aug 18
Draft registration statement (amended)
12:00am
DRS
EX-10.11
3puxcndq8wwu
22 Jun 18
Draft registration statement
12:00am
DRS
lz9oy n9euz2ph
22 Jun 18
Draft registration statement
12:00am
- Prev
- 1
- Next